Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other financing activities (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Other financing activities for 9 consecutive years, with $5.9 million as the latest value for Q1 2026.

  • For Q1 2026, Other financing activities fell 25.13% year-over-year to $5.9 million; the TTM value through Mar 2026 reached $13.9 million, down 29.24%, while the annual FY2025 figure was $15.9 million, 1.22% up from the prior year.
  • Other financing activities hit $5.9 million in Q1 2026 for Select Medical Holdings, up from $2.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $12.1 million in Q2 2023 and bottomed at $141000.0 in Q3 2022.
  • Average Other financing activities over 5 years is $4.1 million, with a median of $3.0 million recorded in 2025.
  • Year-over-year, Other financing activities crashed 99.01% in 2022 and then skyrocketed 3907.8% in 2023.
  • Select Medical Holdings' Other financing activities stood at $2.4 million in 2022, then rose by 1.56% to $2.5 million in 2023, then surged by 154.85% to $6.3 million in 2024, then crashed by 53.33% to $2.9 million in 2025, then skyrocketed by 102.31% to $5.9 million in 2026.
  • According to Business Quant data, Other financing activities over the past three periods came in at $5.9 million, $2.9 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.